DiRECT study: 23% of participants remained in T2DM remission at five yearsThe latest results from a three-year extension of the DiRECT study reveal that for some people it’s possible to stay in remission from...
Laekna and Eli Lilly to develop ActRIIA antibody for muscle-preserving weight loss in obesity6 hours ago